The amendment is that Bill S-5, in clause 18, be amended by replacing line 36 on page 12 to line 17 on page 13 with the following:
product, means (a) that the product (i) contains a drug that is set out in the prescription drug list, as amended from time to time, established under subsection 29 .1 (I) of the Food and Drugs Act, or a drug that is part of a class of drugs that is set out in that list, and (ii) is the subject of an authorization issued under that Act authorizing its sale; or (b) that the product contains a controlled substance, as defined in subsection 2(1) of the Controlled Drugs and Substances Act, the sale or provision of which is authorized under that Act.
What that does is allow for decisions to be made, although currently there aren't necessarily any prescription products that are included for vaping. There's some research in the United States on that, and there may be some prescription products coming up that could be administered by a vaping product. This would allow the regulators to authorize the use of this substance if something comes up that is found to be beneficial and can be given in a prescription.